Harzianic Acid Activity against Staphylococcus aureus and Its Role in Calcium Regulation

Toxins (Basel). 2023 Mar 24;15(4):237. doi: 10.3390/toxins15040237.

Abstract

Staphylococcus aureus is a Gram-positive bacterium, which can be found, as a commensal microorganism, on the skin surface or in the nasal mucosa of the human population. However, S. aureus may become pathogenic and cause severe infections, especially in hospitalized patients. As an opportunistic pathogen, in fact, S. aureus interferes with the host Ca2+ signaling, favoring the spread of the infection and tissue destruction. The identification of novel strategies to restore calcium homeostasis and prevent the associated clinical outcomes is an emerging challenge. Here, we investigate whether harzianic acid, a bioactive metabolite derived from fungi of the genus Trichoderma, could control S. aureus-induced Ca2+ movements. First, we show the capability of harzianic acid to complex calcium divalent cations, using mass spectrometric, potentiometric, spectrophotometric, and nuclear magnetic resonance techniques. Then, we demonstrate that harzianic acid significantly modulates Ca2+ increase in HaCaT (human keratinocytes) cells incubated with S. aureus. In conclusion, this study suggests harzianic acid as a promising therapeutical alternative against diseases associated with Ca2+ homeostasis alteration.

Keywords: Staphylococcus aureus; Trichoderma; calcium; chelation; fungi; secondary metabolites.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Calcium / metabolism
  • Humans
  • Keratinocytes
  • Nasal Mucosa / microbiology
  • Staphylococcal Infections* / drug therapy
  • Staphylococcal Infections* / microbiology
  • Staphylococcus aureus* / metabolism

Substances

  • Calcium
  • harzianic acid

Grants and funding

This study was carried out within the Agritech National Research Center and was funded by Bio Inspired Plant Protection project, PRIN 2020 2020T58TA3—CUP: B63C22000580001 and the European Union Next–Generation EU (PIANO NAZIONALE DI RIPRESA E RESILIENZA (PNRR)—MISSIONE 4 COMPONENTE 2, INVESTIMENTO 1.4—D.D. 1032 17/06/2022, CN00000022). This manuscript reflects only the authors’ views and opinions neither the European Union nor the European Commission can be considered responsible for them.